Mark R. Walter

9.0k total citations · 2 hit papers
106 papers, 6.9k citations indexed

About

Mark R. Walter is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mark R. Walter has authored 106 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Immunology, 37 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Mark R. Walter's work include Immune Cell Function and Interaction (35 papers), Cytokine Signaling Pathways and Interactions (33 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). Mark R. Walter is often cited by papers focused on Immune Cell Function and Interaction (35 papers), Cytokine Signaling Pathways and Interactions (33 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). Mark R. Walter collaborates with scholars based in United States, Germany and United Kingdom. Mark R. Walter's co-authors include Sidney Pestka, Christopher Krause, Naomi J. Logsdon, Tattanahalli L. Nagabhushan, Paul B. Fisher, Devanand Sarkar, Yufang Shi, Brandi C. Jones, Paul P. Trotta and Kristopher Josephson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mark R. Walter

103 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interferons, interferon‐like cytokines, and their receptors

2004 1.3k citations Sidney Pestka, Christopher Krause et al. Immunological Reviews profile →
I nterleukin -10 and R elated C ytokines and R eceptors

2004 904 citations Sidney Pestka, Christopher Krause et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark R. Walter United States	40	4.0k	2.1k	1.9k	995	736	106	6.9k
Alexander Scheffold Germany	47	5.3k 1.3×	1.4k 0.6×	1.6k 0.9×	836 0.8×	628 0.9×	110	8.2k
David G. Brooks United States	48	4.6k 1.1×	1.6k 0.7×	2.3k 1.2×	1.4k 1.4×	1.2k 1.7×	120	8.4k
Akira Shibuya Japan	42	5.1k 1.3×	1.1k 0.5×	1.7k 0.9×	734 0.7×	484 0.7×	180	7.5k
Scott D. Boyd United States	41	3.2k 0.8×	1.1k 0.5×	2.2k 1.2×	589 0.6×	702 1.0×	119	6.7k
Carol Clayberger United States	52	7.4k 1.8×	1.4k 0.6×	2.0k 1.1×	1.3k 1.3×	650 0.9×	156	10.7k
Juan José Lasarte Spain	44	2.9k 0.7×	1.8k 0.8×	1.8k 1.0×	1.2k 1.2×	333 0.5×	179	6.2k
Eiichi Nakayama Japan	44	4.2k 1.1×	1.9k 0.9×	2.2k 1.2×	993 1.0×	303 0.4×	184	7.2k
Paul D. Rennert United States	51	6.9k 1.7×	2.0k 0.9×	2.3k 1.2×	723 0.7×	883 1.2×	84	10.6k
Barbara Fazekas de St Groth Australia	45	9.5k 2.4×	1.6k 0.8×	1.4k 0.7×	903 0.9×	438 0.6×	130	11.8k
Marianne Boes Netherlands	45	5.7k 1.4×	838 0.4×	2.4k 1.3×	1.5k 1.5×	646 0.9×	138	9.1k

Countries citing papers authored by Mark R. Walter

Since Specialization

Citations

This map shows the geographic impact of Mark R. Walter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Walter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Walter more than expected).

Fields of papers citing papers by Mark R. Walter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Walter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Walter. The network helps show where Mark R. Walter may publish in the future.

Co-authorship network of co-authors of Mark R. Walter

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Walter. A scholar is included among the top collaborators of Mark R. Walter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Walter. Mark R. Walter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Piepenbrink, Michael S., Ahmed Magdy Khalil, Ahmed Mostafa, et al.. (2024). Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants. SHILAP Revista de lepidopterología. 2(1). 55–55. 3 indexed citations

Chiem, Kevin, Jun‐Gyu Park, Desarey Morales Vasquez, et al.. (2022). Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus. Microbiology Spectrum. 10(5). e0237922–e0237922. 13 indexed citations

Piepenbrink, Michael S., Jun‐Gyu Park, Ashlesha Deshpande, et al.. (2022). Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody. PLoS Pathogens. 18(7). e1010691–e1010691. 18 indexed citations

Ye, Chengjin, Kevin Chiem, Jun‐Gyu Park, et al.. (2021). Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses. Proceedings of the National Academy of Sciences. 118(41). 32 indexed citations

Chiem, Kevin, Desarey Morales Vasquez, Jesus A. Silvas, et al.. (2021). A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo. Journal of Virology. 95(22). e0112621–e0112621. 14 indexed citations

Wilmes, Stephan, Walid Warda, Elizabeth Pöhler, et al.. (2020). Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses. Science Signaling. 13(649). 60 indexed citations

Walter, Mark R.. (2015). Elucidating new drug targets in psoriasis by gene profiling: an opportunity to be seized.. PubMed Central. 3(6). 78–78. 1 indexed citations

Jones, Brandi C., et al.. (2012). Epstein-Barr Virus IL-10 Engages IL-10R1 by a Two-step Mechanism Leading to Altered Signaling Properties. Journal of Biological Chemistry. 287(32). 26586–26595. 25 indexed citations

Schreiber, Gideon & Mark R. Walter. (2010). Cytokine–receptor interactions as drug targets. Current Opinion in Chemical Biology. 14(4). 511–519. 50 indexed citations

10.

Walter, Mark R., et al.. (2007). Isolation of flagellated bacteria implicated in Crohnʼs disease. Inflammatory Bowel Diseases. 13(10). 1191–1201. 98 indexed citations

11.

Gupta, Pankaj, Mark R. Walter, Zao-zhong Su, et al.. (2006). BiP/GRP78 Is an Intracellular Target for MDA-7/IL-24 Induction of Cancer-Specific Apoptosis. Cancer Research. 66(16). 8182–8191. 102 indexed citations

12.

Svane, Inge Marie, Kirsten Nikolajsen, Mark R. Walter, et al.. (2006). Characterization of Monocyte‐Derived Dendritic Cells Maturated With IFN‐α. Scandinavian Journal of Immunology. 63(3). 217–222. 20 indexed citations

13.

Walter, Mark R.. (2004). Structural Analysis of IL-10 and Type I Interferon Family Members and their Complexes with Receptor. Advances in protein chemistry. 68. 171–223. 38 indexed citations

14.

Pestka, Sidney, Christopher Krause, & Mark R. Walter. (2004). Interferons, interferon‐like cytokines, and their receptors. Immunological Reviews. 202(1). 8–32. 1335 indexed citations breakdown →

15.

Pedersen, Anders Elm, Monika Gad, Mark R. Walter, & Mogens H. Claësson. (2003). Induction of regulatory dendritic cells by dexamethasone and 1α,25-Dihydroxyvitamin D3. Immunology Letters. 91(1). 63–69. 73 indexed citations

16.

Logsdon, Naomi J., et al.. (2002). Comparison of Interleukin-22 and Interleukin-10 Soluble Receptor Complexes. Journal of Interferon & Cytokine Research. 22(11). 1099–1112. 82 indexed citations

17.

Walter, Mark R., Ronald Bordens, Tattanahalli L. Nagabhushan, et al.. (1998). Review of Recent Developments in the Molecular Characterization of Recombinant Alfa Interferons on the 40th Anniversary of the Discovery of Interferon. Cancer Biotherapy and Radiopharmaceuticals. 13(3). 143–154. 29 indexed citations

18.

Walter, Mark R.. (1997). Structural Biology of Cytokines, Their Receptors, and Signaling Complexes: Implications for the Immune and Neuroendocrine Circuit. PubMed. 69. 76–98. 5 indexed citations

19.

Walter, Mark R., William T. Windsor, Tattanahalli L. Nagabhushan, et al.. (1995). Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor. Nature. 376(6537). 230–235. 303 indexed citations

20.

Cook, W.J., Leigh J. Walter, & Mark R. Walter. (1994). Drug Binding by Calmodulin: Crystal Structure of a Calmodulin-Trifluoperazine Complex. Biochemistry. 33(51). 15259–15265. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact